CD28-mediated co-stimulation: A quantitative support for TCR signalling

Nature Reviews Immunology

Volumn 3, Issue 12, 2003, Pages 939-951

  Acuto, Oreste ^a   Michel, Frédérique ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLOSPORIN A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLYCOLIPID; INTERLEUKIN 2; INTERLEUKIN 2 INDUCIBLE T CELL KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN TYROSINE KINASE; PROTEIN VAV1; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR NFAT; TYROSINE; UNCLASSIFIED DRUG;

APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CHEMICAL ANALYSIS; CYTOKINE PRODUCTION; DENDRITIC CELL; DNA METHYLATION; EFFECTOR CELL; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CLONE; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROTUBULE ORGANIZING CENTER; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0347505003     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1248     Document Type: Review

References (155)

1. Goodnow, C. C. Pathways for self-tolerance and the treatment of autoimmune diseases. Lancet 357, 2115-2121 (2001).
2. Lafferty, K. J., Misko, I. S. & Cooley, M. A. Allogeneic stimulation modulates the in vitro response of T cells to transplantation antigen. Nature 249, 275-276 (1974).
3. Sharpe, A. H. & Freeman, G. J. The B7-CD28 superfamily. Nature Rev. Immunol. 2, 116-126 (2002).
4. Lenschow, D. J., Walunas, T. L. & Bluestone, J. A. CD28/B7 system of T cell co-stimulation. Annu. Rev. Immunol. 14, 233-258 (1996).
5. Shahinian, A. et al. Differential T cell co-stimulatory requirements in CD28-deficient mice. Science 261, 609-612 (1993). The first group to describe the CD28 knockout mouse, illustrating that some, but not all, immune responses are affected (see also reference 13).
6. H2 response to Schistosoma mansoni infection. Eur. J. Immunol. 26, 2448-2455 (1996).
7. + T lymphocytes during infection with Listeria monocytogenes. J. Immunol. 167, 5620-5627 (2001).
8. Compton, H. L. & Farrell, J. P. CD28 co-stimulation and parasite dose combine to influence the susceptibility of BALB/c mice to infection with Leishmania major. J. Immunol. 168, 1302-1308 (2002).
9. Salomon, B. & Bluestone, J. A. Complexities of CD28/B7: CTLA-4 co-stimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 19, 225-252 (2001).
10. Via, C. S., Rus, V., Nguyen, P., Linsley, P. & Gause, W. C. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD. J. Immunol. 157, 4258-4267 (1996).
11. -/- mice. J. Immunol. 157, 4822-4829 (1996).
12. Krinzman, S. J. et al. Inhibition of T cell co-stimulation abrogates airway hyperresponsiveness in a murine model. J. Clin. Invest. 98, 2693-2699 (1996).
13. Green, J. M. et al. Absence of B7-dependent responses in CD28-deficient mice. Immunity 1, 501-508 (1994).
14. Lucas, P. J., Negishi, I., Nakayama, K., Fields, L. E. & Loh, D. Y. Naive CD28-deficient T cell can initiate but not sustain an in vitro antigen-specific immune response. J. Immunol. 154, 5757-5768 (1995).
15. Gudmundsdottir, H., Wells, A. D. & Turka, L. A Dynamics and requirements of T cell clonal expansion in vivo at the single-cell level: effector function is linked to proliferative capacity. J. Immunol. 162, 5212-5223 (1999).
16. + T cells. J. Exp. Med. 179, 819-830 (1994).
17. Ferguson, S. E., Han, S., Kelsoe, G. & Thompson, C. B. CD28 is required for germinal center formation. J. Immunol. 156, 4576-4581 (1996).
18. H2 cytokines. J. Immunol. 158, 658-665 (1997).
19. Schweitzer, A. N., Borriello, F., Wong, R. C., Abbas, A. K. & Sharpe, A. H. Role of co-stimulators in T cell differentiation: studies using antigen-presenting cells lacking expression of CD80 or CD86. J. Immunol. 158, 2713-2722 (1997).
20. Prilliman, K. R. et al. Cutting edge: a crucial role for B7-CD28 in transmitting T help from APC to CTL. J. Immunol. 169, 4094-4097 (2002).
21. Borriello, F. et al. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6, 303-313 (1997).
22. + T cells. Immunol. Rev. 165, 231-247 (1998).
23. Kane, L. P., Lin, J. & Weiss, A. It's all Rel-ative: NF-κB and CD28 co-stimulation of T-cell activation. Trends Immunol. 23, 413-420 (2002). A review of co-stimulation on nuclear factor-κB (NF-κB) activation.
24. Michel, F. et al. CD28 utilizes Vav-1 to enhance TCR-proximal signaling and NF-AT activation J. Immunol. 165, 3820-3829 (2000).
25. Diehn, M. et al. Genomic expression programs and the integration of the CD28 co-stimulatory signal in T cell activation. Proc. Natl Acad. Sci. USA 99, 11796-11801 (2002). A microarray study showing that CD28 augments the level of expression of genes targeted by T-cell receptor (TCR)-induced activation: a support to a quantitative view of co-stimulation (see also reference 62).
26. Rincon, M. & Flavell, R. AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes. EMBO J. 13, 4370-4381 (1994).
27. Zuckerman, L. A., Pullen, L. & Miller, J. Functional consequences of co-stimulation by ICAM-1 on IL-2 gene expression and T cell activation. J. Immunol. 160, 3259-3268 (1998).
28. Zhou, X. Y. et al. Molecular mechanisms underlying differential contribution of CD28 versus non-CD28 co-stimulatory molecules to IL-2 promoter activation. J. Immunol. 168, 3847-3854 (2002).
29. Green, J. M., Karpitskiy, V., Kimzey, S. L. & Shaw, A. S. Coordinate regulation of T cell activation by CD2 and CD28. J. Immunol. 164, 3591-3595 (2000).
30. Van Der Merwe, P. A. & Davsi, S. J. Molecular interactions mediating T cell antigen recognition. Annu. Rev. Immunol. 21, 659-684 (2003). A review on the biophysical basis of immunoreceptor recognition.
31. Shimaoka, M. et al. Structures of the αL I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation. Cell 112, 99-111 (2003).
32. Herold, K. C. et al. Regulation of C-C chemokine production by murine T cells by CD28/B7 co-stimulation. J. Immunol. 159, 4150-4153 (1997).
33. Park, W. R. et al. CD28 co-stimulation is required not only to induce IL-12 receptor but also to render janus kinases/STAT4 responsive to IL-12 stimulation in TCR-triggered T cells. Eur. J. Immunol. 31, 1456-1464 (2001),
34. Walker, L. S., Gulbranson-Judge, A., Flynn, S., Brocker, T. & Lane, P. J. Co-stimulation and selection for T-cell help for germinal centres: the role of CD28 and OX40. Immunol. Today 21, 333-337 (2000).
35. Reichert, P., Reinhardt, R. L., Ingulli, E. & Jankins, M. K. Cutting edge: in vivo identification of TCR redistribution and polarized IL-2 production by naive CD4 T cells. J. Immunol. 166, 4278-4281 (2001).
36. Bonnevier, J. L. & Mueller, D. L. Cutting Edge: B7/CD28 interactions regulate cell cycle progression independent of the strength of TCR signaling. J. Immunol. 169, 6659-6663 (2002).
37. Kundig, T. M. et al. Immune responses in interleukin-2-deficient mice. Science 262, 1059-1061 (1993).
38. + T cell survival but not for antigen proliferation. Nature Immunol. 1, 54-58 (2000).
39. Appleman, L. J., Berezovskaya, A., Grass, I. & Boussiotis, V. A. CD28 co-stimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression. J. Immunol. 164, 144-151 (2000).
40. 1 cell-cycle progression by oncogenes and tumor suppressor genes. Curr. Opin. Genet. Dev. 12, 47-52 (2002).
41. Boonen, G. J. et al. CD28 induces cell cycle progression by IL-2-independent downregulation of p27kip1 expression in human peripheral T lymphocytes. Eur. J. Immunol. 29, 789-798 (1999).
42. Kovalev, G. I., Franklin, D. S., Coffield, V. M., Xiong, Y. & Su, L. An important role of CDK inhibitor p18(INK4c) in modulating antigen receptor-mediated T cell proliferation. J. Immunol. 167, 3285-3292 (2001).
43. 1 that controls entry into the cell cycle. Mol. Cell Biol. 23, 2351-2361 (2003).
44. 1-phase progression. Genes Dev. 13, 1501-1512 (1999).
45. Appleman, L. J., van Puijenbroek, A. A., Shu, K. M., Nadler, L. M. & Boussiotis, V. A. CD28 co-stimulation mediates downregulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells. J. Immunol. 168, 2729-2736 (2002).
46. Polymenis, M. & Schmidt, E. V. Coordination of cell growth with cell division. Curr. Opin. Genet. Dev. 9, 76-80 (1999).
47. Schmelzle, T. & Hall, M.N. TOR, a central controller of cell growth. Cell 103, 253-262 (2000).
48. Sears, R. C. & Nevins, J. R. Signaling networks that link cell proliferation and cell fate. J. Biol. Chem. 277, 11617-11620 (2002).
49. Perez, V. L. et al. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6, 411-417 (1997).
50. Rathmell, J. C. & Thompson, C. B. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell 109, S97-S107 (2002).
51. Gett, A. V., Sallusto, F., Lanzavecchia, A. & Geginat, J. T cell fitness determined by signal strength. Nature Immunol. 4, 355-360 (2003).
52. Noel, P. J., Boise, L. H., Green, J. M. & Thompson, C. B. CD28 co-stimulation prevents cell death during primary T cell activation. J. Immunol. 157, 636-642 (1996).
53. Schwartz, R. H. T cell energy. Annu. Rev. Immunol. 21, 305-334 (2003).
54. L. Immunity 3, 87-98 (1995).
55. + lymphocytes. J. Immunol. 165, 1743-1754 (2000).
56. Wan, Y. Y. & DeGregori, J. The survival of antigen-stimulated T cells requires NF-κB-mediated inhibition of p73 expression. Immunity 18, 331-342 (2003).
57. Murphy, K. M. & Reiner, S. L. The lineage decisions of helper T cells. Nature Rev. Immunol. 2, 933-944 (2002).
58. Lanzavecchia, A. & Sallusto, F. Progressive differentiation and selection of the fittest in the immune response. Nature Rev. Immunol. 2, 982-987 (2002).
59. Grogan, J. L. et al. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity 14, 205-215 (2001).
60. Ben-Sasson, S. Z., Gerstel, R., Hu-Li, J. & Paul, W. E. Cell division is not a 'clock' measunng acquisition of competence to produce IFN-γ or IL-4. J. Immunol. 166, 112-120 (2001).
61. H2 differentiation in allergic airway inflammation. Nature Immunol. 2, 45-50 (2001).
62. Riley, J. L. et al. Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proc. Natl Acad. Sci. USA 99, 11790-11795 (2002).
63. H2 differentiation. J. Immunol. 163, 2634-2639 (1999).
64. H2 lineage commitment, Nature Immunol. 4, 182-188 (2003).
65. Zhao, K. et al. Rapid and phosphoinositol-dependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling. Cell 95, 625-636 (1998).
66. Attema, J. L. et al. The human IL-2 gene promoter can assemble a positioned nucleosome that becomes remodeled upon T cell activation. J. Immunol. 169, 2466-2476 (2002).
67. Grogan, J. L. & Locksley, R. M. T helper cell differentiation: on again, off again. Curr. Opin. Immunol. 14, 366-372 (2002).
68. Rao, S., Gerondakis, S., Woltring, D. & Shannon, M. F. c-Rel is required for chromatin remodeling across the IL-2 gene promoter. J. Immunol. 170, 3724-3731 (2003).
69. Bruniquel, D. & Schwartz, R. H. Selective, stable demethylation of the interleukin-2 gene enhances transcnption by an active process. Nature Immunol. 4, 236-240 (2003). The authors provided the first evidence of stable demethylation of a TCR/CD28-targeted gene minutes after triggering.
70. H cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nature Immunol. 3, 643-651 (2002).
71. Acuto, O., Omata-Mise, S., Mangino, G. & Michel, F. Molecular modifiers of T cell antigen receptor triggering threshold: the mechanism of CD28 co-stimulatory receptor. Immunol. Rev. 185, 1-11 (2003).
72. Samelson, L. E. Signal transduction mediated by the T cell antigen receptor: the role of adapter proteins. Annu. Rev. Immunol. 20, 371-394 (2002).
73. Ward, S. CD28: a signaling perspective. Biochem. J. 318, 361-377 (1996).
74. Montixi, C. et al. Engagement of T cell receptor triggers its recruitment to low-density detergent-insoluble membrane domains. EMBO J. 17, 5334-5348 (1998).
75. Irles, C. et al. CD45 ectodomain controls interaction with GEMs and Lck activity for optimal TCR signaling. Nature Immunol. 4, 189-197 (2003).
76. Michel, F., Attal-Bonnefoy, G., Mangino, G., Mise-Omata, S. & Acuto, O. CD28 as a molecular amplifier extending TCR ligation and signaling capabilities. Immunity 15, 935-945 (2001). This paper provides evidence that CD28 signalling amplifies a cyclosporin-dependent pathway by activating a TEC protein tyrosine kinase (PTK) with consequent activation of phospholipase C-γ1 (PLC-γ1) and increase in calcium concentration. It supports the view that co-stimulation directly augments TCR-signalling capability (see also reference 125).
77. Dower, N. A. et al. RasGRP is essential for mouse thymocyte differentiation and TCR signaling. Nature Immunol. 1, 317-321 (2000).
78. Ward, S. G. & Cantrell, D. A. Phosphoinositide 3-kinases in T lymphocyte activation. Curr. Opin. Immunol. 13, 332-338 (2001).
79. Irvine, D. J., Purbhoo, M. A., Krogsgaard, M. & Davis, M. M. Direct observation of ligand recognition by T cells. Nature 419, 845-849 (2002).
80. Rudd, C. E. Upstream-downstream: CD28 cosignal pathways and T cell function. Immunity 4, 527-534 (1996).
81. Yang, W. C., Ghiotto, M., Barbarat, B. & Olive, D. The role of Tec protein-tyrosine kinase in T cell signaling. J. Biol. Chem. 274, 607-617 (1999).
82. August, A. et al. CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line. Proc. Natl Acad. Sci. USA 91, 9347-9351 (1994).
83. Klasen, D., Pages, F., Peyron, J.-F., Cantrell, D. A. & Olive, D. Two distinct regions of the CD28 intracytoplasmic domain are involved in the tyrosine phosphorylation of Vav and GTPase activating protein-associated p62 protein. Int. Immunol. 10, 481-489 (1998).
84. Michel, F., Grimaud, L., Tuosto, L. & Acuto, O. Fyn and ZAP-70 are required for Vav phosphorylation in T cells stimulated by antigen-presenting cells. J. Biol. Chem. 273, 31932-31938 (1998).
85. Parry, R. V. et al. Ligation of the T cell co-stimulatory receptor CD28 activates the serine-threonine protein kinase protein kinase B. Eur. J. Immunol. 27, 2495-2501 (1997).
86. Cantrell, D. Protein kinase B (Akt) regulation and function in T lymphocytes. Semin. Immunol. 14, 19-26 (2002).
87. Okkenhaug, K. et al. A point mutation in CD28 distinguishes proliferative signals from survival signals. Nature Immunol. 2, 325-332 (2001).
88. L. J. Immunol. 166, 5331-5335 (2001).
89. Harada, Y. et al. Critical requirement for the membrane-proximal cytosolic tyrosine residue for CD28-mediated co-stimulation in vivo. J. Immunol. 166, 3797-3803 (2001).
90. Coudronniere, N., Villalba, M., Englund, N. & Altman, A. NF-κB activation induced by T cell receptor/CD28 co-stimulation is mediated by protein kinase C-θ. Proc. Natl Acad. Sci. USA 97, 3394-3399 (2000).
91. H2 cytokines. Nature Immunol. 2, 37-44 (2001).
92. Beals, C. R., Sheridan, C. M., Turck, C. W., Gardner, P. & Crabtree, G. R. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 275, 1930-1934 (1997).
93. Frauwirth, K. A. et al. The CD28 signaling pathway regulates glucose metabolism. Immunity 16, 769-777 (2002).
94. Takesono, A., Finkelstein, L. D. & Schwartzberg, P. L. Beyond calcium: new signaling pathways for Tec family kinases. J. Cell Sci. 115, 3039-3048 (2002).
95. Reynolds, L. F. et al. Vav1 transduces T cell receptor signals to the activation of phospholipase C-γ1 via phosphoinositide 3-kinase-dependent and-independent pathways. J. Exp. Med. 195, 1103-1114 (2002).
96. Wulfing, C. & Davis, M. M. A receptor/cytoskeletal movement triggered by co-stimulation during T cell activation. Science 282, 2266-2269 (1998).
97. Nunès, J. A., Collette, Y., Truneh, A., Olive, D. & Cantrell, D. A. The role of p21ras in CD28 signal transduction: triggering of CD28 with antibodies, but not the ligand B7-1, activates p21ras. J. Exp. Med. 180, 1067-1076 (1994).
98. Hcells. Nature Immunol. 3, 46-54 (2002).
99. + T cells. Immunity 11, 399-409 (1999).
100. H2 cytokine production. Immunity 8, 115-124 (1998).
101. Marinari, B. et al. Vav cooperates with CD28 to induce NF-κB activation via a pathway involving Rac-1 and mitogen-activated kinase kinase 1. Eur. J. Immunol. 32, 447-456 (2002).
102. Hehner, S. P., Hofmann, T. G., Dienz, O., Droge, W. & Schmitz, M. L. Tyrosine-phosphorylated Vav1 as a point of integration for T-cell receptor- and CD28-mediated activation of JNK, p38, and interleukin-2 transcription. J. Biol. Chem. 275, 18160-18171 (2000).
103. Crooks, M. E. et al. CD28-mediated co-stimulation in the absence of phosphatidylinositol 3-kinase association and activation. Mol. Cell Biol. 15, 6820-6828 (1995).
104. Kim, H. H., Tharayil, M. & Rudd, C. E. Growth factor receptor-bound protein 2 SH2/SH3 domain binding to CD28 and its role in co-signaling. J. Biol. Chem. 273, 296-301 (1998).
105. Aghazadeh, B., Lowry, W. E., Huang, X.-Y. & Rosen, M. K. Structural basis for relief of autoinhibition of the Dbl homology domain of proto-oncogene Vav by tyrosine phosphorylation. Cell 102, 625-633 (2000).
106. Michel, F. & Acuto, O. CD28 co-stimulation: a source of Vav-1 for TCR signaling with the help of SLP-76? Sci. STKE 2002, PE35 (2002).
107. Turner, M. & Billadeau, D. D. VAV proteins as signal integrators for multi-subunit immune-recognition receptors. Nature Rev. Immunol. 2, 476-486 (2002).
108. Nunès, J. A., Truneh, A., Olive, D. & Cantrell, D. A Signal transduction by CD28 co-stimulatory receptor on T cells. J. Biol. Chem. 271, 1591-1598 (1996).
109. Tuosto, L., Michel, F. & Acuto, O. p95vav associates with tyrosine-phosphorylated SLP-76 in antigen-stimulated T cells. J. Exp. Med. 184, 1161-1166 (1996).
110. Myung, P. S. et al. Differential requirement for SLP-76 domains in T cell development and function. Immunity 15, 1011-1026 (2001).
111. Penninger, J. M. & Crabtree, G. R. The actin cytoskeleton and lymphocyte activation. Cell 96, 9-12 (1999).
112. Wulfing, C., Bauch, A., Crabtree, G. R. & Davis, M. M. The vav exchange factor is an essential regulator in actin-dependent receptor translocation to the lymphocyte-antigen-presenting cell interface. Proc. Natl Acad. Sci. USA 97, 10150-10155 (2000).
113. Krawczyk, C. et al. Vav1 controls integdn clustering and MHC/peptide-specific cell adhesion to antigen-presenting cells. Immunity 16, 331-343 (2002).
114. Ardouin, L. et al. Vav1 transduces TCR signals required for LFA-1 function and cell polarization at the immunological synapse. Eur. J. Immunol. 33, 790-797 (2003).
115. Manetz, T. S. et al. Vav1 regulates phospholipase Cγ activation and calcium responses in mast cells. Mol. Cell Biol. 21, 3763-3774 (2001).
116. Cantrell, D. A. Phosphoinositide 3-kinase signalling pathways. J. Cell. Sci. 114, 1439-1445 (2001).
117. Raab, M., Pfister, S. & Rudd, C. E. CD28 signaling via VAV/SLP-76 adaptors: regulation of cytokine transcription independent of TCR ligation. Immunity 15, 921-933 (2001).
118. Carey, M. The enhanceosome and transcriptional synergy. Cell 92, 5-8 (1998).
119. June, C. H., Ledbetter, J. A., Gillespie, M. M., Lindsten, T. & Thompson, C. B. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell. Biol. 7, 4472-4481 (1987).
120. Rooney, J. W., Sun, Y. L., Glimcher, L. H. & Hoey, T. Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation. Mol. Cell. Biol. 15, 6299-6310 (1995).
121. + thymocytes. J. Exp. Med. 190, 943-952 (1999).
122. Su, B. et al. JNK is involved in signal integration during co-stimulation of T lymphocytes. Cell 77, 727-736 (1994).
123. Rivas, F. V., O'Herrin, S. & Gajewski, T. F. CD28 is not required for c-Jun N-terminal kinase activation in T cells. J. Immunol. 167, 3123-3128 (2001).
124. Miller, A. T. & Berg, L. J. New insights into the regulation and functions of Tec family tyrosine kinases in the immune system. Curr Opin. Immunol. 14, 331-340 (2002).
125. Tuosto, L. & Acuto, O. CD28 affects the earliest signaling events generated by TCR engagement. Eur. J. Immunol. 28, 2131-2142 (1998).
126. Viola, A., Schroeder, S. Sakakibara, Y. & Lanzavecchia, A. T lymphocyte co-stimulation mediated by reorganization of membrane microdomains. Science 283, 680-682 (1999). This paper provides evidence for a role of co-stimulation in facilitating the clustering of glycolipid-enriched membrane microdomains (GEMs).
127. Bromley, S. K. et al. The immunological synapse and CD25-CD80 interactions. Nature Immunol. 2, 1159-1166 (2001).
128. Holdorf, A. D. et al. Proline residues in CD28 and the S1rc homology (SH)3 domain of Lck are required for T cell co-stimulation. J. Exp. Med. 190, 375-384 (1999).
129. Herndon, T. M., Shan, X. C., Tsokos, G. C. & Wange, R. L. ZAP-70 and SLP-76 regulate protein kinase C-θ and NF-κB activation in response to engagement of CD3 and CD28. J. Immunol. 166, 5654-5664 (2001).
130. Huang, J. et al. CD28 plays a critical role in the segregation of PKCθ within the immunologic synapse. Proc. Natl Acad. Sci. USA 99, 9369-9373 (2002).
131. Wetzel, S. A., McKeithan, T. W. & Parker, D. C. Live-cell dynamics and the role of co-stimulation in immunological synapse formation. J. Immunol. 169, 6092-6101 (2002).
132. Wulfing, C. et al. Co-stimulation and endogenous MHC ligands contribute to T cell recognition. Nature Immunol. 3, 42-47 (2002). Using live immunofluorescence, this paper shows that CD28 contributes to TCR triggering by facilitating the accumulation of TCRs (including non-ligated TCRs) at the immune synapse (see also reference 131).
133. Harder, T. & Simons, K. Clusters of glycolipid and glycosylphosphatidylinositol-anchored proteins in lymphoid cells: accumulation of actin regulated by local tyrosine phosphorylation. Eur. J. Immunol. 29, 556-562 (1999).
134. Freiberg, B. A. et al. Staging and resetting T cell activation in SMACs. Nature Immunol. 3, 911-917 (2002).
135. Iezzi, G., Karjalainen, K. & Lanzavecchia, A. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 8, 89-95 (1998). This work illustrates the point that CD28 signalling decreases the duration of TCR stimulation in determining T-cell fate (see also reference 145).
136. Holdorf, A. D., Lee, K. H., Burack, W. R., Allen, P. M. & Shaw, A. S. Regulation of Lck activity by CD4 and CD28 in the immunological synapse. Nature Immunol. 3, 259-264 (2002).
137. Jun, J. E. et al. Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis. Immunity 18, 751-762 (2003). This paper describes a point mutation in CARMA1, which is associated with lipid rafts after immunoreceptor triggering (see reference 138), that affects some but not all of the signalling pathways in which NF-κB is implicated: an example of qualitative differences in biological response with a minimum change in the behaviour of a single signalling component (see also reference 146).
138. Gaide, O. et al. CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-κB activation. Nature Immunol. 3, 836-843 (2002).
139. Lewis, R. S. Calcium signaling mechanisms in T lymphocytes. Annu. Rev. Immunol. 19, 497-521 (2001).
140. Viola, A. & Lanzavecchia, A. T cell activation determined by T cell receptor number and tunable thresholds. Science 273, 104-106 (1996). The first evidence that ligation of CD28 decreases the threshold number of ligated TCRs that are required for a given biological response.
141. Manickasingham, S. P., Anderton, S. M., Burkhart, C. & Wraith, D. C. Qualitative and quantitative effects of CD28/B7-mediated co-stimulation on naive T cells in vitro. J. Immunol. 161, 3827-3835 (1998).
142. H1 cytokine production. J. Immunol. 161, 2762-2771 (1998).
143. H2 differentiation is directly dependent on the dose of antigen. J. Immunol. 164, 2955-2963 (2000).
144. Deenick, E. K., Gett, A. V. & Hodgkin, P. D. Stochastic model of T cell proliferation: a calculus revealing IL-2 regulation of precursor frequencies, cell cycle time, and survival. J. Immunol. 170, 4963-4972 (2003).
145. Kündig, T. M. et al. Duration of TCR stimulation determines co-stimulatory requirements of T cells. Immunity 5, 41-52 (1996). The first in vivo data that support a quantitative model of co-stimulation.
146. Gong, Q. et al. Disruption of T cell signaling networks and development by Grb2 haploid insufficiency. Nature Immunol. 2, 29-36 (2001). An example of how sensitive certain biological responses are to a relatively small variation of a signalling component.
147. Arendt, C. W., Albrecht, B., Soos, T. J. & Littman, D. R. Protein kinase C-θ: signaling from the center of the T-cell synapse. Curr. Opin. Immunol. 14, 323-330 (2002).
148. Villalba, M. et al. Translocation of PKCθ in T cells is mediated by a nonconventional, P13-K- and Vav-dependent pathway, but does not absolutely require phospholipase C. J. Cell. Biol. 157, 253-263 (2002).
149. Koretzky, G. A. & Myung, P. S. Positive and negative regulation of T-cell activation by adaptor proteins. Nature Rev. Immunol. 1, 95-107 (2001).
150. Griffiths, E. K. & Penninger, J. M. Communication between the TCR and integrins: role of the molecular adapter ADAP/Fyb/Slap. Curr. Opin. Immunol. 14, 317-322 (2002).
151. Wang, H. et al. SKAP-55 regulates integrin adhesion and formation of T cell-APC conjugates. Nature Immunol. 4, 366-374 (2003).
152. Heyeck, S. D., Wilcox, H. M., Bunnell, S. C. & Berg, L. J. Lck phosphoyrlates the activation loop tyrosine of the Itk kinase domain and activates Itk kinase activity. J. Biol. Chem. 272, 25401-25408 (1997).
153. Yang, W. C., Ching, K. A., Tsoukas, C. D. & Berg, L. J. Tec kinase signaling in T cells is regulated by phosphatidylinositol 3-kinase and the Tec pleckstrin homology domain. J. Immunol. 166, 387-395 (2001).
154. Krawczyk, C. et al. Cbl-b is a negative regulator of receptor clustering and raft aggregation in T cells. Immunity 13, 463-473 (2000).
155. Chuang, E. et al. The CD28 and CTLA-4 receptors associate with the sedne/threonine phosphatase PP2A. Immunity 13, 313-322 (2000).